A combination of carrier erythrocytes and artificial nanoparticles as a promising approach for drug delivery: a review
by Nadeesha Athukorala; Sanath Rajapakse; S.D.S.S. Sooriyapathirana
International Journal of Nanoparticles (IJNP), Vol. 15, No. 1, 2023

Abstract: The need for extensive drug delivery research was fuelled by the increasing awareness of how drug release patterns affect therapeutic responses and the necessity for safe and efficient drug administration. Scientists understood that novel therapies are possible when a drug is encapsulated within or attached to a carrier. It has thus become clear that drug carrier systems are essential as the drug itself. Nanotechnology's applications in drug delivery have been reported to improve therapeutic outcomes. Nevertheless, challenges related to biocompatibility, cytotoxicity, and rapid clearance have limited the use of nanomedicine. After extensive research, erythrocyte membrane camouflaged nanoparticles loaded with drugs have become an attractive candidate for drug delivery. This strategy has offered an opportunity to unite the properties of natural cell membrane with that of nanoparticles. This paper reviews the development and importance of the combined strategy and provides a foundation to stimulate the interest in this novel strategy.

Online publication date: Thu, 04-Jan-2024

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanoparticles (IJNP):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com